Cellular Senescence in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms, Pathogenic Networks, and Emerging Therapeutic Targets
Diseases · 04.06.2026 · 14 (6) · 201
DOI: 10.3390/diseases14060201 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 04.06.2026. Verfasst von Madina B Baurzhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Balneology and Medical Rehabilitation, Ministry of Health of the Republic of Kazakhstan, Astana 010000, Kazakhstan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan, Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by irreversible extracellular matrix deposition and high mortality, with aging representing its strongest risk factor. Increasing evidence suggests that cellular senescence is not merely a consequence of tissue injury but a central driver of disease progression. Senescent alveolar epithelial cells and fibroblasts contribute to impaired tissue repair and persistent fibrotic remodeling through the acquisition of a senescence-associated secretory phenotype (SASP), which promotes chronic inflammation and amplifies profibrotic signaling. This review provides a comprehensive synthesis of current evidence on the role of cellular senescence in IPF, focusing on key molecular mechanisms, including telomere attrition, mitochondrial dysfunction, oxidative stress, DNA damage response activation, and dysregulated transforming growth factor-β (TGF-β) signaling. A structured literature search was conducted using the PubMed, Scopus, and Web of Science databases to identify mechanistic, translational, and clinical studies related to cellular senescence in IPF. Relevant studies were selected based on conceptual relevance and scientific quality, and findings were qualitatively synthesized within a narrative-review framework. These interconnected pathways form self-reinforcing feedback loops that stabilize the senescent phenotype and sustain fibroblast activation. In addition, we critically evaluate emerging therapeutic strategies targeting senescence, including senolytic and senomorphic approaches, highlighting their potential to modify fundamental disease mechanisms rather than solely attenuating fibrotic progression. Preclinical and early clinical studies suggest that selective targeting of senescent cells may represent a promising avenue for intervention, although challenges related to specificity, safety, and biomarker development remain. Overall, this review positions cellular senescence as a central mechanistic link between aging and fibrosis and underscores its relevance as a translational target in IPF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute of Balneology and Medical Rehabilitation, Ministry of Health of the Republic of Kazakhstan, Astana 010000, Kazakhstan.
- Laboratory of Drug Discovery and Development, Nazarbayev University, Astana 010000, Kazakhstan.
- Joint-Stock Company "Karaganda Medical University", Karaganda 100008, Kazakhstan.
- Non-Profit Joint-Stock Company «Kazakh National Medical University Named After S.D. Asfendiyarov», Almaty 050000, Kazakhstan.
- Department of Internal Medicine, Faculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
- Department of Neurology, Kazakh-Russian Medical University, Almaty 050004, Kazakhstan.
ORCID-Profile: Madina B Baurzhan, Karlygash S Absattarova, Kuat Abzaliyev
Förderung
- The Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan
- Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Baurzhan, M. B., Gulyayev, A. E., Absattarova, K. S., Kairgeldina, S. A., Abzaliyev, K., Izbassarova, A., Lepessova, M., & Absatarova, K. (2026). Cellular Senescence in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms, Pathogenic Networks, and Emerging Therapeutic Targets. Diseases, 14(6), 201. https://doi.org/10.3390/diseases14060201
Vancouver
Baurzhan MB, Gulyayev AE, Absattarova KS, Kairgeldina SA, Abzaliyev K, Izbassarova A, et al. Cellular Senescence in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms, Pathogenic Networks, and Emerging Therapeutic Targets. Diseases. 2026;14(6):201. doi:10.3390/diseases14060201
BibTeX
@article{Baurzhan2026,
author = {Baurzhan, Madina B and Gulyayev, Alexandr E and Absattarova, Karlygash S and Kairgeldina, Sayagul A and Abzaliyev, Kuat and Izbassarova, Akmaral and Lepessova, Marzhan and Absatarova, Karashash},
title = {Cellular Senescence in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms, Pathogenic Networks, and Emerging Therapeutic Targets},
journal = {Diseases},
year = {2026},
volume = {14},
number = {6},
pages = {201},
doi = {10.3390/diseases14060201}
}
EUVIMED